Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin
J. Clin. Invest. Kamal Rahmouni, et al. 114:652
doi:10.1172/JCI21737 [Go to this article.]

Figure 5
Effects of PI3K and MAPK blockade on lumbar and BAT SNA responses to another stimulus, CRF. (A) The PI3K inhibitors LY294002 (5 μg; ICV) and wortmannin (0.5 μg; ICV) have no effect on the lumbar sympathoactivation to CRF (5 μg; ICV). (B) The MAPK inhibitors PD98059 (5 μg; ICV) and U0126 (7 μg; ICV) have no effect on the BAT sympathoactivation to CRF (5 μg; ICV). Data represent means ± SEM of 8–10 rats per group.